Saltar al contenido principal
Elsevier

Advances in Immunology

  • 1 Edición, Volumen 143 - 11 de octubre de 2019
  • Última edición
  • Editor: Frederick W. Alt
  • Idioma: Inglés

Advances in Immunology, Volume 143, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immun… Leer más

Descripción

Advances in Immunology, Volume 143, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, with this release focusing on the design of vaccine strategies to elicit HIV-1 broadly neutralizing antibodies, gender bias, fungi, fibrinolysis and allergic airway inflammation, updating and interpreting airway epithelial cell reprogramming in bronchial asthma, the link(s) of sensing to the immune response, and the regulatory role of the autonomic system.

Puntos claves

  • Presents current developments and comprehensive reviews in immunology
  • Provides the latest in a longstanding, respected serial on the subject matter
  • Focuses on recent advances in the advancing area of the mechanisms involved in the evolution of HIV-1 neutralizing antibodies

De interès para

Immunologists and infectious disease specialists, cell biologists and hematologists

Índice

1. Neuronal regulation of group 2 innate lymphoid cells and type 2 inflammation
Saya Moriyama and David Artis

2. Antibody responses to the HIV-1 envelope high mannose patch
Christine Daniels and Kevin O. Saunders

3. Origin and function of synovial macrophage subsets during inflammatory joint disease
Stephan Culemann, Anika Grüneboom and Gerhard Krönke

4. Models of dendritic cell development correlate ontogeny with function
David A. Anderson III and Kenneth M. Murphy

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 143
  • Publicado: 11 de octubre de 2019
  • Idioma: Inglés

Sobre el editor

FA

Frederick W. Alt

Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Afiliaciones y experiencia
Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USA

Ver libro en ScienceDirect

Lee Advances in Immunology en ScienceDirect